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Expression of a Putative
Vesicular Acetylcholine Transporter
Facilitates Quantal Transmitter Packaging
Hong-jun Song,* Guo-li Ming,* Edward Fon,² putative VAChT cDNA predicts a protein with 12 putative
transmembrane domains. In situ hybridization has dem-Elizabeth Bellocchio,² Robert H. Edwards,²
onstrated specific localization of the putative VAChTand Mu-ming Poo*
mRNA in cholinergic cell groups, and immunostaining*Department of Biology
has shown the expected localization of VAChT proteinUniversity of California at San Diego
in cell bodies and terminals of cholinergic neuronsLa Jolla, California 92093
(Schafer et al., 1994; Gilmor et al., 1996). Interestingly,²Departments of Neurology and Physiology
specific promoters for the putative VAChT gene resideUniversity of California at San Francisco
within the first intron of the gene for choline acetyltrans-San Francisco, California 94143
ferase (ChAT), and coordinated expression of VAChT
and ChAT has recently been observed in sympathetic
superior cervical neurons (Berse and Blusztajn, 1995;Summary
Berrard et al., 1995; Cervini et al., 1995; Misawa et al.,
1995). Despite strong circumstantial evidence for itsA putative vesicular acetylcholine transporter (VAChT)
identity as the ACh transporter, the physiological func-was overexpressed in developing Xenopus spinal neu-
tion of the putative VAChT has been difficult to dem-rons by injection of rat VAChT cDNA or synthetic
onstrate directly. Nonneural cell lines that supportmRNA into Xenopus embryos. This resulted in a
heterologous expression of the vesicular monoaminemarked increase in the amplitude and frequency of
transporters do not support significant VAChT functionminiature excitatory postsynaptic currents at neuro-
(Erickson et al., 1994). However, high level expressionmuscular synapses, reflecting an over 10-fold increase
of VAChT in the pheochromocytoma cell line PC12 ap-in the vesicular packaging of acetylcholine (ACh). The
pears to confer ACh transport into membrane vesicleseffect appeared in developing neurons even before
(Varoqui and Erickson, 1996). In the present study, wesynaptogenesis and was blocked by L-vesamicol, a
have examined the function of VAChT in a neuronalspecific blocker of ACh uptake into synaptic vesicles.
environment by expressing the putative rat VAChT cDNAMutational studies showed that two highly conserved
or synthetic mRNA in developing Xenopus spinal neu-aspartate residues within putative transmembrane do-
rons before the quantal transmitter secretion hadmains 4 and 10 are essential for the transport activity.
reached maturity.These results provide direct evidence for the physio-
During the first few days in culture, cholinergic Xeno-logical function of a putative VAChT and demonstrate
pus spinal neurons establish functional synaptic trans-
that quantal size can be regulated by changes in vesic-
mission with cocultured myocytes (Evers et al., 1989).
ular transporter activity.
At these developing neuromuscular synapses, action
potential±independent miniature excitatory postsynap-
tic currents (MEPCs) exhibit a wide variation in the peak
Introduction amplitude. The amplitude distribution of the quantal
events is skewed toward smaller amplitudes (Kidokoro
Synaptic transmission depends on the packaging of et al., 1980; Evers et al., 1989). In contrast, the amplitude
neurotransmitter into synaptic vesicles and the synchro- distribution of MEPCs at mature neuromuscular junc-
nous exocytosis of these vesicles upon arrival of an tions assumes a Gaussian profile around the mean am-
action potential in the nerve terminal. Studies of cholin- plitude (bell-shaped distribution), which defines the
ergic vesicles purified from the electric organ of Torpedo quantal size (del Castillo and Katz, 1954; Boyd and Mar-
have identified a vesicular transport activity for acetyl- tin, 1956). The transition from a skewed to a bell-shaped
choline (ACh) (Parsons et al., 1993). This activity de- distribution occurs during the first week in Xenopus
pends on a proton electrochemical gradient generated nerve±muscle cultures, a process that appears to reflect
by a vacuolar type H1±ATPase and is selective for ACh. both a maturation of vesicular ACh packaging and an
The compound vesamicol blocks cholinergic neuro- increase in receptor density at the subsynaptic mem-
transmission by interfering with vesicular ACh storage brane. Previous studies have shown that in 1-day-old
(Prior et al., 1992), and binding studies suggest that Xenopus nerve±muscle culture the variation in the MEPC
vesamicol interacts directly with the transporter (Par- amplitude is primarily due to a variation in the amount
sons et al., 1993). Recent studies of C. elegans mutants of ACh contained in the ACh packets, rather than differ-
that are defective in neuromuscular function have led ences in the postsynaptic ACh sensitivity or the amount
to the identification of the gene unc-17 (Alfonso et al., of acetylcholinesterase at the synapse (Evers et al.,
1993). Based on its expression in cholinergic nerve end- 1989). In particular, the amplitude distribution of MEPCs,
ings and the striking sequence similarity to a vesicular which is highly skewed toward smaller values, suggests
transporter for monoamines (Liu et al., 1992; Erickson incomplete ACh filling of most synaptic vesicles. In the
et al., 1992), the unc-17 gene product was proposed to present study, we took advantage of the immature sta-
be the vesicular ACh transporter (VAChT). Homologous tus of ACh packaging in developing neurons to examine
genes were later cloned from Torpedo, rat, and human the function of VAChT by overexpressing the protein. A
(Bejanin et al., 1994; Erickson et al., 1994; Roghani et shift in the amplitude distribution toward larger sizes
would indicate higher levels of ACh per vesicle, and theal., 1994; Varoqui et al., 1994). Sequence analysis of the
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transition from a skewed to a bell-shaped amplitude protein. Interestingly, the endogenous Xenopus protein
distribution would suggest quantal maturation. The ele- appeared to have a similar MW as the rat protein. The
vated ACh transport activity may also increase the fre- presence of VAChT protein in cultured Xenopus cells
quency of MEPCs, since more vesicles loaded with suffi- was also examined by immunocytochemical staining of
cient ACh would be available to generate detectable 1-day-old cultures, using antibodies to rat VAChT. In
current events after exocytosis. two separate cultures, 52 of 55 dextran-positive cells
The rat VAChT cDNA or synthetic mRNA was ex- showed strong immunostaining for VAChT, whereas 54
pressed in Xenopus neurons by injection into the early of 60 dextran-negative cells revealed veryweak staining.
blastomeres of Xenopus embryos. Previous studies We also performed double immunofluorescence stain-
have shown that introducing exogenous cDNA or mRNA ingwith antibodies to thesynaptic vesicle protein synap-
into the blastomeres of early Xenopus embryos results tophysin as well as VAChT. As depicted by the examples
in the expression of exogenous proteins in the progeny in Figures 1B±1D, the level of VAChT staining in neurons
neurons and muscle cells derived from the injected blas- derived from injected blastomeres showed substantial
tomere. Presynaptic functions of spinal neurons were variation, while the level was much higher compared
found to be affected by the presence of these foreign with that of neurons derived from noninjected blasto-
proteins at the neuromuscular junction (Alder et al., meres in the same culture. In contrast, a similar level of
1995). In the present study, we found that theexpression punctuate staining of synaptophysin was observed in
of rat VAChT by injection of either cDNA or mRNA leads different neurons. Double immunostaining of the same
to a marked enhancement of ACh packaging at devel- neurons showed that the expressed VAChT molecules
oping synapses, an effect which is observed only when are largely colocalized with synaptophysin, particularly
VAChT is expressed in the presynaptic neurons, not in those associated with punctuate staining, suggesting
the postsynaptic muscle cells. This effect can be seen the expression of VAChT in synaptic vesicles.
in developing neurons prior to synaptogenesis and is
blocked by L-vesamicol, a specific blocker of ACh up-
take into synaptic vesicles. Mutational studies further Quantal ACh Secretion at Developing Synapses
indicate that two conserved aspartate residues pre- Within 1 day following cell plating, many neurons and
dicted to reside in the putative transmembrane domains muscle cells formed functional synapses (Buchanan et
4 and 10 are essential for its function. Taken together, al., 1989; Evers et al., 1989). Spontaneous quantal trans-
these results provide strong evidence that this protein mitter release at the neuromuscular synapse was as-
acts as the vesicular ACh transporter in neurons. Fur- sayed electrophysiologically by whole-cell recording of
thermore, expression of VAChT during development ap- synaptic currents from the postsynaptic muscle cell. In
pears to be a limiting factor in determining the transmit- 1-day-old cultures, MEPCs recorded from postsynap-
ter quantal size. Regulation of VAChT activity may thus tic muscle cells exhibited variable amplitude and fre-
provide a means of modulating the efficacy of synaptic quency. These current events were due to spontaneous
transmission. quantal release of ACh from the presynaptic neuron, as
they were insensitive to tetrodotoxin (TTX), an agent
known to block action potentials in this culture (Xie andResults
Poo, 1986). The mean frequency and mean amplitude
of MEPCs after treatment with TTX (10 mM) were 109% 6Expression of Putative VAChT in Developing
10% and 95% 6 9% (SEM, n 5 10), respectively, ofXenopus Neurons
the values observed at the same synapse before theRat VAChT cDNA or synthetic mRNA prepared from the
treatment. However, when the properties of MEPCscDNA was injected into one of the early blastomeres of
were examined at synapses made by neurons derivedXenopus embryos at the 2-cell stage. Dextran conju-
from Xenopus blastomeres injected with VAChT cDNAgated with fluorescein isothiocyanate (FITC±dextran)
[VAChT(1)] or from noninjected blastomeres [VAChT(2)]was coinjected with the cDNA or mRNA as a fluores-
in the same culture, a marked difference was observed.cence marker for the identification of progeny cells de-
As shown by the pair of recordings depicted in Figurerived from the injected blastomere. Cultures of dissoci-
2A, both the mean amplitude and the mean frequencyated spinal neurons and muscle cells were prepared
of MEPCs were much higher at synapses made by thefrom these embryos 1 day after injection (see Experi-
VAChT(1) neuron. Since both the presynaptic neuronmental Procedures). The expression of putative rat
(N) and the postsynaptic myocyte (M) may express (1)VAChT in the Xenopus cellswas confirmed first by West-
or may not express (2) the exogenous VAChT, we haveern analysis of the embryos injected with VAChT cDNA
analyzed the mean peak amplitude and frequency ofor mRNA, using polyclonal antibodies raised against
MEPCs for four possible combinations: N1M1, N1M2,the C-terminus of the rat VAChT protein, which has a
N2M1, or N2M2. As shown in Figure 2B, higher valuespredicted MW of 56.5 kDa (Gilmor et al., 1996). Figure
were observed when the neuron was VAChT(1), irre-1A shows a much higher level of the protein at z55 kDa
spective of the expression in the postsynaptic musclein the injected embryos as compared with the nonin-
cell.A relative assessment of theoverall amount of spon-jected embryos 1 day after injection of the cDNA or
taneous vesicular secretion of ACh was also made bymRNA for VAChT. The weak staining of noninjected em-
integrating the current over time to obtain the totalbryos may reflect expression of endogenous Xenopus
charge associated with all MEPCs within a unit of timeVAChT protein at a lower level, or a poor recognition of
Xenopus VAChT by the antibodies raised against the rat (min) at each synapse. This measure integrates changes
Putative VAChT Facilitates Packaging of ACh Quanta
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Figure 1. Expression of Putative Rat VAChT in Xenopus Embryos after Blastomere Injection
(A) Western blot analysis of rat VAChT in noninjected and injected embryos at the indicated time after fertilization, using polyclonal antibodies
against the putative rat VAChT. Putative VAChT cDNA or mRNA was injected into one of the early blastomeres of Xenopus embryos at the
2-cell stage. Proteins from one embryo were loaded into each lane. The size of molecular weight markers is shown on the left side. The arrow
indicates a band at z55 kDa, which is likely to represent the VAChT protein (Gilmor et al., 1996).
(B±D) Immunostaining of Xenopus neurons with both antibodies against rat VAChT (left, by red fluorescence) and against rat synaptophysin
(middle, by green fluorescence). Colocalization of VAChT with synaptophysin was indicated as yellow in the superimposed images (right).
Arrows point to putative synaptic vesicle clusters. Shown in the insert are images of the neurons at a lower magnification. Note the different
levels of expression of rat VAChT in two cells derived from the same injected blastomere ([B] and [C]) and the absence of staining in the
neuron derived from the noninjected blastomere (D) in the same culture. Scale, 10 mm (60 mm for the insert).
in both the frequency and the amplitude of MEPCs, and VAChT facilitates ACh packaging into synaptic vesicles,
which only occurs with VAChT expression in the presyn-we have found a .10-fold increase in the total amount
of ACh released from VAChT(1) neurons. These results aptic neuron. Since expression in the muscle cells had
no effect on the properties of MEPCs, we have groupedare consistent with the expectation that exogenous rat
Neuron
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Figure 2. Effect of Expressing Putative VAChT on Spontaneous MEPCs Observed at Developing Xenopus Neuromuscular Synapses in Culture
(A) Membrane currents recorded from a whole-cell voltage-clamped myocyte that was innervated by a neuron expressing rat VAChT (upper
traces), or a control neuron not expressing rat VAChT (middle traces), or a neuron expressing the empty vector (bottom traces), as identified
by the presence or absence of FITC±dextran fluorescence. Traces on the left are recordings of membrane currents at a slow timescale;
downward deflections represent MEPCs. Traces on the right are overlapped oscilloscopic sweeps of membrane currents at a faster timescale
observed over 1 min. Scale bars, 0.5 nA, 1 min and 0.5 nA, 20 ms for the slow and fast traces, respectively.
(B) Average values of MEPC amplitude, frequency, and total charge at neuromuscular synapses in cultures obtained from embryos injected
with rat VAChT cDNA. Data are grouped according to the expression of VAChT in the presynaptic neuron (N) and/or the postsynaptic myocyte
(M), as determined by the presence of FITC±dextran fluorescence. Numbers associated with the bar refer to the total number of synapses
examined. The same set of data was used for the analyses of amplitude, frequency, and charge. Error bars 5 SEM. Significance level was
indicated by `*' (p , 0.05) and `**' (p , 0.01), using a Student's t-test.
(C) Similar to (B), except that the data are grouped according to whether the presynaptic neuron was expressing VAChT or an empty vector
pcDNA I used for carrying the VAChT cDNA. Values for VAChT(1) differ significantly from control values obtained from the same cultures, as
marked by `**' (p , 0.01) or `*' (p , 0.05, t-test). In contrast, values for empty vector(1) were not different from their own control values
(unmarked bracket, p . 0.05, t-test). The same set of data as that in (B) was used for the VAChT group.
the results regardless of thestatus of muscle expression I(1)] showed no detectable change in the measurements
of MEPCs compared with control synapses [pcDNA I(2)]in the summary histograms shown in Figure 2C. In con-
trast to the marked effect on amplitude and frequency, in the same set of cultures. The results are summarized
in the histograms shown in Figure 2C.the rise and decay times of MEPCs showed no signifi-
cant difference in all cases (data not shown), suggesting
no obvious effects of VAChT expression on the distribu-
tion, density, or conductance properties of postsynaptic Amplitude Distribution of MEPCs
To determine the effect of VAChT on ACh packaging,ACh channels. Finally, to determine whether the microin-
jection of DNA alone perturbed secretion, we have intro- further analysis of the MEPC amplitude distribution was
performed. The increase in the mean amplitude couldduced a pcDNA I vector without the rat VAChT cDNA into
Xenopus embryos. MEPCs in cultures prepared from the result from a general shift of quantal size toward larger
amplitudes or from the appearance of a subpopulationinjected embryos were recorded as described above.
We found that synapses made by neurons derived from of quanta with large amplitudes. Figure 3 depicts typical
examples of MEPC amplitude distributions at synapsesthe blastomeres injected with the empty vector [pcDNA
Putative VAChT Facilitates Packaging of ACh Quanta
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Figure 3. Amplitude Distribution of MEPCs
The top three rows depict representative his-
tograms of MEPC amplitude distribution ob-
tained from individual myocytes innervated
by neurons derived from noninjected blasto-
meres (A), or from blastomeres injected with
an empty pcDNA I vector (B) or a vector con-
taining VAChT cDNA (C).
(D) Comparison of the amplitude distribution
of MEPCs. The cumulative probability refers
to the percentage of all events with ampli-
tudes smaller than or equal to a given value.
Data are obtained from synapses made by
(1) neurons expressing VAChT (n 5 28), (2)
control neurons not expressing VAChT in the
same group of embryos as in (1) (n 5 29),
(3) neuron expressing empty vector pcDNA I
(n 5 16), (4) control neurons not expressing
the empty vector in the same group of em-
bryosas in (3) (n 5 17), (5) neurons expressing
VAChT but treated with 2 mM L-vesamicol
(n 5 9), and (6) control neurons not express-
ing VAChT in the same group of embryos as
in (5) (n 5 11). Bar 5 SEM. The data for
VAChT(1) neurons are significantly different
from all other groups (p , 0.01, Kolmogorov±
Smirnov test). The data for VAChT(1) and
VAChT(2) with vesamicol are also signifi-
cantly different from all other groups (p ,
0.01, Kolmogorov±Smirnov test), but are not
significantly different from each other (p .
0.05, Kolmogorov±Smirnov test).
made by control neurons derived from noninjected blas- 3D. The distribution of MEPC amplitudes for synapses
made by VAChT(1) neurons was found to be signifi-tomeres and neurons derived from blastomeres loaded
with the empty vector alone or with VAChT cDNA. The cantly different from that for synapses made by pcDNA
I(1), VAChT(2), or pcDNA I(2) neurons (p , 0.01, Kolmo-noninjected control and empty vector control synapses
showed a monotonic skewed distribution of MEPCs, as gorov-Smirnov test). In a separate series of experiments,
in vitro transcribed mRNA madefrom cDNA encoding ratdescribed previously, at these developing synapses (Xie
and Poo, 1986; Evers et al., 1989). In 35 of 42 noninjected VAChT, rather than thecDNA, was injected into Xenopus
blastomeres. Similar enhancement of MEPC amplitudecontrol and in 17 of 19 empty vector(1) synapses, the
smallest amplitude bin (0±100 pA) contained the highest and frequency was observed at synapses made by neu-
rons derived from mRNA-injected blastomeres (Figurenumber of events. In contrast, only 5 of 29 VAChT(1)
synapses exhibited the most frequent events at this 4A). The cumulative probability plot for the amplitude
distribution of MEPCs was found to be indistinguishablebin. Furthermore, 10 of 29 synapses made by VAChT(1)
neurons showed a distinct Gaussian profile at higher from that observed with cDNA injection (Figure 4B).
amplitudes, reminiscent of the amplitude distribution of
MEPCs observed at more mature synapses in these Effect of L-(2)-vesamicol
Previous pharmacological studies have shown thatcultures (Lu et al., 1992). In contrast, such a Gaussian
profile of MEPC amplitude was rarely observed at nonin- L-vesamicol specifically inhibits ACh packaging into
synaptic vesicles (Prior et al., 1992). In addition, L-vesa-jected control and empty vector(1) synapses (1 of 42
and 1 of 19, respectively). micol binding has been used as evidence for the physio-
logical function of the putative VAChT (Erickson et al.,Quantitative comparison of the amplitude distribution
between various groups of synapses was made by con- 1994). If the effects that we observed on quantal secretion
were due to increased transporter activity, L-vesamicolstructing the cumulative probability plot shown in Figure
Neuron
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Figure 4. Effect of Injection with Putative Rat
VAChT mRNA
(A) Average values of MEPC amplitude, fre-
quency, and total charge at synapses made
by neurons derived from blastomeres in-
jected with synthetic rat VAChTmRNA(1) and
neurons from noninjected blastomeres in the
same group of embryos (2). Data are grouped
according to the expression of VAChT mRNA
in the presynaptic neuron, regardless of the
expression in the postsynaptic myocyte.
Numbers associated with the bar refer to the
total number of synapses examined. Error
bars 5 SEM. Data for (1) are significantly
different from those for (2) (p , 0.01; t-test).
(B) Comparison of amplitude distribution of
MEPCs. Cumulative probability was calcu-
lated as described in Figure 3D. Data are ob-
tained from synapses made by (1) neurons
expressing rat VAChT mRNA (n 5 19), (2) con-
trol noninjected neurons in the same group of
embryos as in group one (n 5 21), (3) neurons
injected with VAChT cDNA (n 5 28), and (4)
control noninjected neurons in the same
group of embryos as in group three (n 5 29).
Data for groups three and four are the same
as those shown for groups one and two in
Figure 3D. Error bar 5 SEM. The data for
VAChT mRNA(1) and VAChT cDNA(1) are
significantly different from their respective
noninjected controls (p , 0.01, Kolmogorov±
Smirnov test), but are not different from each
other (p . 0.05, Kolmogorov±Smirnov test).
should block them. At control VAChT(2) synapses de- vesamicol treatment. Thus, it is unlikely that vesamicol
had any significant effect on the postsynaptic ACh sen-rived from noninjected Xenopus blastomeres, we found
that treatment with 2 mM of L-(2)-vesamicol markedly sitivity under these experimental conditions.
reduced the amplitude, frequency, and total charge of
MEPCs, without apparent effect on the time course of Increased ACh Packaging in Isolated
Neurons prior to Synaptogenesisthe individual events (Figure 5). This effect on the synap-
tic currents was presumably due to reduced ACh loading It is well known that postsynaptic cells exert retrograde
influence on the differentiation of presynaptic neurons,by endogenous VAChT. With the same vesamicol treat-
ment, we found that the mean amplitude and frequency including determination of transmitter phenotype (Lan-
dis, 1990). Although the presence of VAChT in the post-of MEPCs at synapses made by VAChT(1) neurons were
reduced to the same levels as those from synapses synaptic myocyte did not affect the enhancement of
ACh packaging in VAChT(1) neurons, it is nonethelessmade by control VAChT(2) neurons treated with vesami-
col (Figure5; also see Figure 3D). Both the rise and decay possible that the action of presynaptically expressed
VAChT in ACh packaging depends on the presence oftimes of MEPCs were unaffected (data not shown). The
residual amount of quantal ACh secretion in vesamicol- postsynaptic muscle cells. We have therefore deter-
mined whether increased ACh packaging can occur intreated culturesmay result from either incomplete inhibi-
tion of VAChT by vesamicol or VAChT-independent isolated neurons prior to the contact with the myocyte.
In Xenopus cultures, previous studies have shown thatmechanisms of vesicular ACh accumulation.
To confirm that vesamicol did not affect postsynaptic spontaneous and evoked ACh secretion can occur prior
to synaptogenesis, using a myocyte or an excised patchsensitivity toACh, we directlyassayed the effect of vesa-
micol on the ACh sensitivity of the muscle cells, using of muscle membrane as a detector of the released ACh
(Young and Poo, 1983; Sun and Poo, 1987). In the pres-iontophoretic application of identical ACh pulses at the
muscle surface. We found that in the presence of 2 mM ent study, we examined MEPCs that occurred immedi-
ately following the contact with a manipulated myocyte,of L-(2)-vesamicol the average peak amplitude of ACh-
induced currents was 108% 6 10% (SEM, n 5 10 cells) assuming that spontaneous quantal release at this early
time involves the exocytosis of vesicles packaged priorof that observed at myocytes in the absence of the
Putative VAChT Facilitates Packaging of ACh Quanta
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Figure 5. Effect of L-(2)-Vesamicol on Quantal
ACh Secretion
(A) Continuous traces depict examples of
membrane currents recorded from a whole-
cell voltage-clamped myocyte (Vc 5 270 mV)
that was innervated by a VAChT(1) neuron
(upper trace) or by a VAChT(2) neuron (lower
trace) in the presence of 2 mM L-(2)-vesami-
col, which was added to the culture medium
at the time of cell plating. Samples of MEPCs
at various times are shown below at a higher
time resolution. Scale bars, 100 pA, 1.5 min
and 100 pA, 20 ms for slow and fast time-
scales, respectively.
(B) Histograms for the amplitude distribution
of MEPCs at synapses made by VAChT(1)
and VAChT(2) neurons in the presence
(crossed) and absence (shaded) of L-(2)-ves-
amicol (2 mM). Relative frequencyrefers to the
percentage of events associated with each
amplitude bin. Error bar 5 SEM.
(C±E) Averaged values of the amplitude, fre-
quency, and total charge of MEPCs at syn-
apses made by VAChT(1) and VAChT(2) neu-
rons in the presence and absence of L-(2)-
vesamicol (2 mM). The number associated
with the bars refers to the total number of
synapses examined. Error bar 5 SEM. Values
from synapses in the presence of vesamicol
were significantly different from those in the
absence of vesamicol (`**', p , 0.01, t-test).
However, values from VAChT(1) and
VAChT(2) in the presence of vesamicol are
not significantly different from each other (un-
marked bracket, p . 0.05, t-test).
to the myocyte contact. After achieving whole-cell re- Two Aspartate Residues Essential
for the Transporter Functioncording of an isolated spherical myocyte, the cell was
manipulated into contact with growth cones of isolated To explore the molecular mechanism of the VAChT func-
tion, we introduced two single mutations into the ratspinal neurons in the same culture (Figure 6A). The im-
mediate appearance of MEPCs, previously shown to be VAChT by site-directed mutagenesis. As illustrated in
Figure 7A, mutation D193N involves a replacement ofinduced by contact (Xie and Poo, 1986), was assayed
during the first 5 min following the initial contact of the an aspartate residue in transmembrane domain 4 with
asparagine. This residue shows conservation in all themyocyte. To minimize the effect due to the variation in
ACh sensitivity of the myocyte, the same myocyte was VAChT cDNAs from different species, but not in the
vesicular monoamine transporters, suggesting a possi-used to measure ACh release from several growth cones
of both VAChT(1) and VAChT(2) neurons in the same ble role in substrate recognition. The second mutation
D398N involves a similar replacement of aspartate 398culture in a random order. An example of recordings
made by a myocyte from two different growth cones is in transmembrane domain 10 with asparagine. This resi-
due is conserved among all vesicular neurotransmittershown in Figure 6B. We found that the mean amplitude,
frequency, and total charge of MEPCs were much higher transporters identified so far. Neutralization of the ho-
mologous residue in monoamine transporters disruptsfor VAChT(1) neurons (Figure 6C). The higher level of
quantal ACh secretion during the initial phase of neuron± the function (Steiner-Mordoch et al., 1996; Merickel et
al., 1997). In vitro synthesized mRNA for the VAChTmuscle contact supports the notion that the elevated
ACh packaging had occurred prior to the muscle con- mutants was injected into Xenopus blastomeres. West-
ern analysis shows that the mutant proteins were ex-tact. The differences between the VAChT(1) and
VAChT(2) neurons, however, were slightly smaller than pressed in Xenopus embryos at a similar level to wild-
type rat VAChT and exhibited the same electrophoreticthose observed at natural synapses in 1-day-old cul-
tures, suggesting that further enhancement of ACh mobility (Figure 7B). Using cultures prepared from the
injected embryos, we found that D193N completelypackaging had occurred after synapse formation. Some
inductive action of the postsynaptic muscle cell may abolished the transport function of the introduced
VAChT (Figure 7C). Interestingly, D398N reduced thedirectly or indirectly affect further maturation of the
quanta. mean amplitude, frequency, and total charge of MEPCs
Neuron
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Figure 6. Detection of Increased ACh Pack-
aging in Isolated Neurons
(A) Phase-contrast microscopic images of an
isolated Xenopus spinal neuron (N) before
(top) and after (bottom) a whole-cell voltage-
clamped Xenopus myocyte (M) was manipu-
lated into contact with its growth cone. Scale
bar, 50 mm.
(B) Representative traces depict membrane
currents recorded from a whole-cell voltage-
clamped myocyte (Vc 5 270 mV), after it was
first manipulated into contact with the growth
cone of a VAChT(1) neuron for 5 min (upper
trace) and then manipulated into contact with
the growth cone of a VAChT(2) neuron (lower
trace). Samples of MEPCs at various times
are shown below at a higher time resolution.
Arrows indicate the time of nerve±muscle
contact (on) and detachment (off). Scale bars,
300 pA, 45 s and 200 pA, 10 ms for slow and
fast timescales, respectively.
(C) Mean values of MEPC amplitude, fre-
quency, and total charge obtained from 12
pairs of VAChT(1) and VAChT(2) neurons.
Only VAChT(2) myocyte was used in this
assay. `*' marks significant difference (p ,
0.05, t-test).
to a level significantly belowthat of noninjected controls. VAChT by cholinergic neurons, however, the expression
of VAChT cDNA in a variety of cell lines has failed toAgain, the rise and decay times of MEPCs showed no
significant differences in all cases (data not shown), yield ACh transport activity using standard membrane
preparations (E. F., E. B., and R. H. E., unpublished data).suggesting no postsynaptic effects.
One group has reported ACh uptake into intact cells
that shows inhibition by vesamicol (Erickson et al., 1994).Discussion
Surprisingly, a semipermeabilized cell preparation more
appropriate to demonstrate uptake by intracellular vesi-Previous studies have indicated the existence of four
cles did not reveal ACh transport activity. Recently, thedistinct vesicular transporter activities for classical neu-
same group has reported vesamicol-sensitive ACh up-rotransmitters, including those for monoamines, ACh,
take by membranes prepared from PC 12 cells stablyglutamate, and g-aminobutyric/glycine (Sudhof and Jahn,
expressing VAChT (Varoqui and Erickson, 1996), sug-1991; Edwards, 1992; Schuldiner et al., 1995). Molecular
gesting that the transport activity may require expres-cloning has identified two proteins involved in vesicular
sion of the transport protein in a neuroendocrine cell.monoamine transport (VMAT1 and 2), and several bio-
chemical assays have established the physiological Our observations now provide direct physiological evi-
dence of vesicular ACh transport activity by rat VAChTfunction of these proteins in a variety of heterologous
expression systems (Erickson et al., 1992; Liu et al., expressed in a cholinergic neuron.
The blastomere injection method has been used in sev-1992; Schuldiner et al., 1993; Merickel et al., 1995). Simi-
lar to vesicular monoamine transport, vesicular ACh eral previous studies of synaptic vesicle proteins. Over-
expression of rat synaptophysin and synaptotagmintransport involves proton exchange (Parsons et al.,
1993). The sequence similarity of unc-17 and its verte- increased and decreased the frequency of MEPCs, re-
spectively (Alder et al., 1995; T. Morimoto and M. M. P.,brate homologs to VMATs further supports their similar-
ity in function. Despite the selective expression of unpublished data), without affecting the mean amplitude
Putative VAChT Facilitates Packaging of ACh Quanta
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Figure 7. Mutational Studies of Putative VAChT
(A) Schematic drawing of proposed topology of the rat VAChT and the sites of mutations introduced. Mutation D193N has a single amino
acid substitution from aspartate to asparagine at 193 in transmembrane domain 4, a site conserved in all VAChTs identified in different species.
Mutation D398N has the same single amino acid substitution from aspartate to asparagine at 398 in transmembrane domain 10, a site
conserved in all vesicular transporters.
(B) Western analysis of different rat VAChTs in 2-day-old noninjected and injected embryos. Different VAChT mRNAs were injected into one
of the early blastomeres of Xenopus embryos at the 2-cell stage. Total proteins from one embryo 2 days after fertilization were loaded into
each lane. Staining was performed using antibody against rat putative VAChT.
(C) Summary of the effects of various VAChTs on quantal ACh secretion. Data were normalized against the mean value obtained from neurons
derived from noninjected blastomeres in the same group of embryos. Shown are data on MEPCs produced by neurons derived from embryos
injected with empty pcDNA I vector (n 5 19 for vector[1]; n 5 20 for vector[2]), with vector containing VAChT cDNA (30[1]; 29[2]), with
synthetic VAChT mRNA (20[1]; 22[2]), with mutated VAChT D193N mRNA (20[1]; 20[2]), and with VAChT D398N mRNA (18[1]; 21[2]). Error
bar 5 SEM. Data exhibiting a significant difference from their respective noninjected controls are indicated (`*' p , 0.05; `**' p , 0.01;
t-test).
or amplitude distribution of MEPCs. In contrast, overex- sufficient ACh to produce detectable postsynaptic events
(amplitude .10 pA) will be increased. On the other hand,pression of rat VAChT markedly increasesboth themean
amplitude and the frequency of MEPCs. These differ- VAChT may also promote maturation or the formation
and stability of synaptic vesicles, resulting in more filledences provide strong evidence that the effect on the
quantal events found in the present study reflects a vesicles available for spontaneous release. It may also
facilitate exocytosis, leading directly to a higher fre-specific effect on ACh packaging. Thus, although immu-
nostaining of cultured Xenopus neurons indicates that quency of spontaneous ACh release. Nonetheless, a
specific role for this VAChT protein in ACh packagingVAChT colocalizes with synaptophysin, the function of
VAChT in the vesicle clearly differs from that of synapto- is strongly supported by the observation that vesamicol,
a drug known to inhibit ACh transporter function in vivophysin and synaptotagmins, proteins implicated in other
aspects of the synaptic vesicle cycle. and in vitro (Prior et al., 1992), completely blocked the
effects of expressing this protein on MEPCs. A potentialSynapses made by VAChT(1) spinal neurons exhib-
ited MEPCs of larger mean amplitude and higher fre- effect of vesamicol on the ACh sensitivity of the myocyte
was excluded by iontophoretic tests of the ACh sensitiv-quency. The increased amplitude directly reflects larger
amounts of ACh packaged into the synaptic vesicle. The ity of the myocyte after the drug treatment.
The observed effect of VAChT on MEPCs apparentlyincreased ACh packaging may contribute in part to the
increase in frequency, since the number of vesicles with requires its expression in the presynaptic neuron, while
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expression in the postsynaptic muscle cell had no influ- et al., 1997). Since the pH gradient across the vesicle
membrane normally appears to prevent reverse flux byence on MEPCs (Figure 2B). We found that the rise and
decay times of MEPCs were unchanged in all experi- the VMATs (Maron et al., 1983), neutralization of aspar-
tate 398 in VAChT may eliminate its ability to sense themental conditions, regardless of the site of VAChT over-
expression, further arguing against any effect of the gradient. This will promote ACh efflux, thus reducing
the storage of ACh by endogenous Xenopus VAChT.protein expression on postsynaptic ACh channel prop-
erties. Indeed, the postsynaptic muscle seems unlikely In summary, we have provided physiological evidence
that a putative VAChT protein functions as the AChto have an inductive or permissive role for the presynap-
tic action of VAChT. Larger and more frequent quantal transporter across the synaptic vesicle in cholinergic
neurons. Furthermore, our results indicate that quantalrelease was observed immediately following the contact
of the muscle with the VAChT(1) neuron (Figure 6), sug- synaptic transmission can be modulated directly by al-
tering the level of expression of wild-type vesiculargesting that the effect of VAChT on ACh packaging had
begun in the isolated neuron prior to synaptogenesis, transporter or by expressing exogenous mutant pro-
teins. The level of vesicular monoamine transporter con-in the absence of the muscle cell. This result, however,
did not exclude the possibility that the muscle cell can tent of chromaffin granules was found to be elevated
by depolarization of the chromaffin cells (Desnos et al.,exert retrograde influence on further maturation of ACh
packaging following synaptogenesis. 1995). Thus, regulation of vesicular transporter activity
may provide a natural means of modulating the efficacyThe effect of VAChT on the amplitude distribution of
MEPCs varies substantially. Although higher mean am- of synaptic transmission.
plitude was observed in nearly all cases, only a fraction
of synapses exhibited the bell-shaped distribution char-
Experimental Proceduresacteristic of mature quantal secretion. As indicated by
immunostaining of VAChT (Figure 1), there was a sub-
Preparation of cDNA or mRNA for Injection
stantial variation in the expression level among various Rat VAChT cDNA was inserted into the pcDNA I amp vector (In-
neurons. Insufficient expression of the VAChT protein vitrogen) at the EcoR I site. Capped mRNA for VAChT and mutant
may account for the immature packaging of ACh. In VAChTs were prepared from pcDNA I-VAChT, linearized with EcoR
V, and transcribed in vitro using T7 RNA polymerase (mMESSAGEaddition, the clustering of ACh receptors in the postsyn-
mMACHINE, Ambion).aptic muscle membrane contributes directly to the size
of synaptic currents and takes many days to complete.
In these Xenopus cultures, the increase in the amplitude Loading of VAChT cDNA or mRNA
of MEPCs and the appearance of a bell-shaped distribu- into Xenopus Embryos
tion of MEPC amplitudes correlate with the size and Female Xenopus laevis (Xenopus I) were induced to lay eggs using
human chorionic gonadotropin (Sigma), and the eggs were fertilizedfrequency of postsynaptic ACh clusters along the nerve
artificially with testis homogenates. The cDNA construct or mRNAcontact sites during the first few days in culture (Kido-
was suspended in RNase-free H2O mixedwith FITC-conjugateddex-koro et al., 1980).
tran (15 mg/ml). The final concentration of the DNA construct is 2
Mutational studies of rat VAChT indicate the impor-
mg/ml; for mRNA, it is 1 mg/ml. About 2 ng DNA or 1 ng mRNA was
tance of specific amino acid residues in the transport injected into one blastomere of Xenopus embryo at the 2-cell stage
mechanism. Replacement of aspartate 193 by aspara- using a Picosprizer (General Valve, NJ), as described previously
(Alder et al., 1995). The embryos were kept at room temperature forgine completely abolished the enhancement of ACh
24 hr prior to the preparation of dissociated cell cultures.packaging. This residue is conserved in all VAChT se-
quences isolated from different species but not in
VMATs. Our results are consistent with its possible role Immunostaining Analysis
in substrate recognition. In contrast, aspartate 398 For Western analysis, Xenopus embryos were collected at different
time points after in vitro fertilization and homogenized by sonicationshows conservation in VMATs as well as VAChTs. Inter-
in 1% SDS. Proteins from one embryo were loaded onto each lane,estingly, the D398N mutation not only blocked the en-
separated by SDS±polyacrylamide electrophoresis, and blottedhancement of ACh packaging produced by VAChT over-
onto nitrocellulose. The blot was blocked with 10% dry milk in 50expression, but also reduced endogenous Xenopus
mM Tris-buffered saline (TBS) (pH 7.4), followed by incubation with
vesicular ACh transport, as reflected by the reduction polyclonal antibody raised against the C-terminus of the predicted
in the amplitude and frequency of MEPCs (Figure 7C). rat VAChT (Gilmor et al., 1996) (1:1000 dilution) for 1 hr at room
The D398N mutation could exert such an effect through temperature. Membranes were rinsed and incubated for 1 hr with
peroxidase-conjugated goat anti-rabbit IgG (1:1000 dilution) at roommultiple distinct mechanisms. First, the mutant could
temperature. Chemiluminescent detection was performed with thedimerize with endogenous wild-type proteinand prevent
ECL kit (Amersham) as instructed.its activity. However, there is little evidence that any
For immunostaining of cells in cultures, 1-day-old cultures were
member of this family of proteins or any cotransporter or washed in a solution containing 10 mM Tris (pH 7.0), 150 mM NaCl,
exchanger of either Na1 or H1 functions as an oligomer. and 0.05% Tween-20 (TTBS) and blocked with 10% goat serum
Alternatively, the D398N mutant may interfere indirectly in TTBS overnight on a Nutator. They were then incubated with
polyclonal anti-rat VAChT antibodies (rabbit; 1:1000) and mono-with the storage of ACh by dissipating the proton elec-
clonal synaptophysin antibody (mouse; 1:400) in blocking solutiontrochemical driving force for ACh transport or by directly
at room temperature for 2 hr. Cultures were washed five times withcatalyzing the downhill movement of ACh out of synaptic
TTBS, for 1 hr each time, and then incubated in anti-rabbit antibody
vesicles. Interestingly, mutagenesis of the homologous conjugated to flurescensin (1:1000) and anti-mouse antibody conju-
residues in transmembrane domain 10 of both VMATs gated to rhodamine (1:1000) in blocking solution at room tempera-
supports a selective defect in bioenergetic coupling to ture for 2 hr. Following five washes of cultures in TTBS for 1 hr each,
the photographs were taken on a Nikon microscope at 403.the driving force (Steiner-Mordoch et al., 1996; Merickel
Putative VAChT Facilitates Packaging of ACh Quanta
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Construction of Mutant VAChTs Alfonso, A., Grundahl, K., Duerr, J.S., Han, H.P., and Rand, J.B.
Wild-type VAChT was subcloned into pBluescript II SK (Stratagene). (1993). The Caenorhabditis elegans unc-17 gene: a putative vesicu-
Site-directed mutagensis was done by a 2-step PCR protocol. Four lar acetylcholine transporter. Science 261, 617±619.
primers, including 59 and 39 completely overlapping synthetic oligo- Bejanin, S., Cervini, R., Mallet, J., and Berrard, S. (1994). A unique
nucleotide primers (28 bases with the desired mutation in the center) gene organization for two cholinergic markers, choline acetyltrans-
and two flanking primers (T3 and T7 primer), were used with wild- ferase and a putative vesicular transporter of acetylcholine. J. Biol.
type rat VAChT cDNA as the template. Under standard PCR condi- Chem. 269, 21944±21947.
tions, primers were extended in opposite directions using Pfu DNA
Berrard, S., Varoqui, H., Cervini, R., Israel, M., Mallet, J., and Diebler,polymerase (Stratagene) in two separate reactions. In the third PCR,
M.F. (1995). Coregulation of two embedded gene products, cholinethe purified products from the first two PCR reactions were com-
acetyltransferase and the vesicular acetylcholine transporter. J.bined and extended to produce a single fragment with the desired
Neurochem. 65, 939±942.mutation. To verify that the clone by this method contained only the
desired mutation but no others, the region flanking the mutation Berse, B., and Blusztajn, J.K. (1995). Coordinated up-regulation of
was sequenced in its entirety by a DNA sequencer (Perkin Elmer, choline acetyltransferase and vesicular acetylcholine transporter
Applied Biosystems Model 373). Restriction fragments within this gene expression by the retinoic acid receptor alpha, cAMP, and
region were then subcloned back into the VAChT cDNA encoding leukemia inhibitory factor/ciliary neurotrophic factor signaling path-
the wild-type protein. ways in a murine septal cell line. J. Biol. Chem. 270, 22101±22104.
Boyd, I.A., and Martin, A.R. (1956). The end-plate potential in mam-
Culture Preparation
malian muscle. J. Physiol. 132, 74±91.Xenopus nerve±muscle cultures were prepared according to pre-
Buchanan, J., Sun, Y.A., and Poo, M.M. (1989). Studies of nerve-viously reported methods (Spitzer and Lamborghini, 1976; Tabti and
muscle interactions in Xenopus cell culture: fine structure of earlyPoo, 1991) and used for experiments after 1 day of culturing at
functional contacts. J. Neurosci. 9, 1540±1554.room temperature (20±228C). Briefly, the neural tube and associated
myotomal tissue of 1-day-old Xenopus embryos (stage 20±22, ac- Cervini, R., Houhou, L., Pradat, P.F., Bejanin, S., Mallet, J., and
cording to Nieuwkoop and Faber, 1976) were dissociated in Ca21/ Berrard, S. (1995). Specific vesicular acetylcholine transporter pro-
Mg21-free saline supplement with EDTA (115 mM NaCl, 2.6 mM KCl, moters lie within the first intron of the rat choline acetyltransferase
0.4 mM EDTA, and 10 mM HEPES [pH 7.4]) for 15±20 min. The cells gene. J. Biol. Chem. 270, 24654±24657.
were platedon clean glass coverslips and wereused for experiments
del Castillo, J., and Katz, B. (1954). Quantal components of the end-after 24 hr incubation at room temperature. The culture medium
plate potential. J. Physiol. 124, 560±573.consisted of 50% (v/v) of Ringer's solution (115 mM NaCl, 2 mM
Desnos, C., Laran, M.P., Langley, K., Aunis, D., and Henry, J.P.CaCl2, 2.5 mM KCl, and 10 mM HEPES [pH 7.6]), 49% of Leibovitz
(1995). Long term stimulation changes the vesicular monoaminemedium (L15, GIBCO), and 1% fetal bovine serum (GIBCO).
transporter content of chromaffin granules. J. Biol. Chem. 270,
16030±16038.Electrophysiology
Synaptic currents were recorded from innervated muscle cells by Edwards, R.H. (1992). The transport of neurotransmitters into synap-
a whole-cell recording method (Hamill et al., 1981; Young and Poo, tic vesicles. Curr. Opin. Neurobiol. 2, 586±594.
1983). Muscle cells were voltage-clamped at 270 mV. The mem-
Erickson, J.D., Eiden, L.E., and Hoffman, B.J. (1992). Expressionbrane currents were monitored by patch-clamp amplifiers (Axo-
cloning of a reserpine-sensitive vesicular monoamine transporter.patch-1D, Axon Instruments). The membrane currents were filtered
Proc. Natl. Acad. Sci. USA 89, 10993±10997.at 5 kHz, digitized, and stored in a videotape recorder for later
Erickson, J.D., Varoqui, H., Schafer, M.K., Modi, W., Diebler, M.F.,playback onto a storage oscilloscope (Tektronix 5113). Computer
Weihe, E., Rand, J., Eiden, L.E., Bonner, T.I., and Usdin, T.B. (1994).analysis was performed with the SCAN program kindly provided by
Functional identification of a vesicular acetylcholine transporter andDr. J. Dempster (Strathclyde University, UK). The internal solution
its expression from a ``cholinergic'' gene locus. J. Biol. Chem. 269,in the recording pipette for myocytes contained 150 mM KCl, 1 mM
21929±21932.NaCl, 1 mM MgCl2, 5 mM magnesium ATP, 0.5 mM sodium ATP,
and 10 mM HEPES (pH 7.2). Recordings were made at room temper- Evers, J., Laser, M., Sun, Y.A., Xie, Z.P., and Poo, M.M. (1989).
ature in a solution containing 140 mM NaCl, 5 mM KCl, 1 mM CaCl2, Studies of nerve-muscle interactions in Xenopus cell culture: analy-
1 mM MgCl2, and 10 mM HEPES (pH 7.4). For L-(2)-vesamicolexperi- sis of early synaptic currents. J. Neurosci. 9, 1523±1539.
ments, the recording solution contained 2 mM L-(2)-vesamicol. Ion-
Gilmor, M.L., Nash, N.R., Roghani, A., Edwards, R.H., Yi, H., Hersch,tophoresis of ACh was performed by methods previously described
S.M., and Levey, A.I. (1996). Expression of the putative vesicular(Orida and Poo, 1978). To compare the ACh sensitivity on the myo-
acetylcholine transporter in rat brain and localization in cholinergiccyte surface with and without the vesamicol treatment, the tip of
synaptic vesicles. J. Neurosci. 16, 2179±2190.the iontophoretic pipette was positioned tangentially, in contact with
the myocyte surface, and whole-cell membrane currents induced by Hamill, O.P., Marty, A., Neher, E., Sakmann, B., and Sigworth, F.J.
identical 1 ms ACh pulses were measured. The ACh pipette was a (1981). Improved patch-clamp techniques for high-resolution cur-
conventional sharp micropipette pulled by a horizontal puller (Shut- rent recording from cells and cell-free membrane patches. PfluÈ gers
ter Inst.), and filled with 3 M ACh chloride (resistance 100±300 MV). Arch. 391, 85±100.
Repeated mapping of ACh responses at the same site on the cell Kidokoro, Y., Anderson, M.J., and Gruener, R. (1980). Changes in
surface usually yields reproducible membrane currents, with a vari- synaptic potential properties during acetylcholine receptor accumu-
ability of ,10% (Orida and Poo, 1978). lation and neurospecific interactions in Xenopus nerve-muscle cell
culture. Dev. Biol. 78, 464±483.
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